Skip to main content
. Author manuscript; available in PMC: 2009 Sep 17.
Published in final edited form as: Neurogastroenterol Motil. 2008 Aug 5;21(2):149–159. doi: 10.1111/j.1365-2982.2008.01171.x

Table 1.

Clinical characteristics of Study 1 subjects

Description Controls (n = 25) IBS (n = 41) P-value
Age (years ± SEM) 33.0 ± 2.1 39.9 ± 1.5 = 0.01
BMI (±SEM) 26.3 ± 1.3 27.2 ± 1.0 ns
Bowel habits [n (%)] IBS-A 17 (41)
IBS-C 9 (22)
IBS-D 15 (37)
Symptom severity IBS symptom severity (0–20 cm) 10.5 ± 0.8
    Abdominal pain Chronic abdominal pain (unpleasantness) 12.5 ± 0.4
Chronic abdominal pain (intensity) 13.1 ± 0.4
Current abdominal pain (unpleasantness) 8.2 ± 0.7
Current abdominal pain (intensity) 9.6 ± 0.8
Gynaecological history [n (%)]
    Premenopausal phase Follicular 8 (32) 15 (37) ns
Luteal 12 (48) 11 (27)
Menses 1 (4) 4 (10)
Provera 1 (4) 1 (2)
    Postmenopausal 3 (12) 9 (22) ns
    OCP 5 (20) 8 (20) ns
    HRT 1 (4) 1 (2) ns
    Hysterectomy 1 (4) 3 (7) ns
Chronic stress indicators [n (%)] Childhood abuse 4 (16) 8 (20) ns
Adult abuse 1 (4) 10 (25) 0.029
Early adverse event 1 (4) 6 (15) ns
HAD scores Anxiety 3.8 ± 0.625 6.1 ± 0.4 0.002
Depression 2.0 ± 0.6 4.2 ± 0.4 0.003

BMI, body mass index; OCP, oral contraceptive agent; HRT, hormone replacement therapy. Chronic pain symptoms were rated over previous 3 months. Current pain was rated over previous 24 h. For premenopausal women not taking OCP, the menstrual cycle phase was determined by the count forward/backward method: menses, first 3 days of menses; follicular, days 4–14; luteal, day 14 onward and before menses.